Human Genome Epidemiology Literature Finder
Rare Diseases
|
Records 1 - 17 (of 17 Records) |
| Query Trace: Anaplastic Oligodendroglioma[original query] |
|---|
| Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 2002 1 8 (1): 196-201. Ueki Keisuke, Nishikawa Ryo, Nakazato Yoichi, Hirose Takanori, Hirato Junko, Funada Nobuaki, Fujimaki Takamitsu, Hojo Shuntaro, Kubo Osami, Ide Takafumi, Usui Masaaki, Ochiai Chikayuki, Ito Shoichi, Takahashi Hiroshi, Mukasa Akitake, Asai Akio, Kirino Takaa |
| Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clinical cancer research : an official journal of the American Association for Cancer Research 2004 Apr 10 (8): 2618-25. Okcu MF, Selvan M, Wang LE, Stout L, Erana R, Airewele G, Adatto P, Hess K, Ali-Osman F, Groves M, Yung AW, Levin VA, Wei Q, Bondy M |
| Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience. Journal of neuro-oncology 2013 Aug 114 (1): 85-91. Frenel J S, Leux C, Loussouarn D, Le Loupp A-G, Leclair F, Aumont M, Mervoyer A, Martin S, Denis M G, Campone |
| 1p/19q codeletion and IDH1/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas. Neuro-oncology 2013 Mar . Jiang H, Ren X, Cui X, Wang J, Jia W, Zhou Z, Lin S |
| Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China. Journal of cancer research and clinical oncology 2014 Jan 140 (1): 45-51. Zhang Chuan-Bao, Bao Zhao-Shi, Wang Hong-Jun, Yan Wei, Liu Yan-Wei, Li Ming-Yang, Zhang Wei, Chen Ling, Jiang T |
| Molecular investigation of isocitrate dehydrogenase gene (IDH) mutations in gliomas: first report of IDH2 mutations in Indian patients. Asian Pacific journal of cancer prevention : APJCP 2013 14 (12): 7261-4. Das Bibhu Ranjan, Tangri Rajiv, Ahmad Firoz, Roy Arnab, Patole Kamlak |
| Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
| The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients. Turkish neurosurgery 2016 Aug . Hacisalihoglu Payam, Kucukodaci Zafer, Gundogdu Gokcen, Bilgic Bil |
| Prevalence of IDH1/2 Mutations in Different Subtypes of Glioma in the North-East Population of Morocco. Asian Pacific journal of cancer prevention : APJCP 2016 17 (5): 2649-53. Senhaji Nadia, Louati Sara, Chbani Laila, Bardai Sanae El, Mikou Karima, Maaroufi Mustafa, Benzagmout Mohammed, Faiz Mohammed Chaoui El, Marie Yannick, Mokhtari Karima, Idbaih Ahmed, Amarti Afaf, Bennis San |
| Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach. Journal of clinical pathology 2016 Jan . Rajmohan K S, Sugur Harsha S, Shwetha S D, Ramesh Arvind, Thennarasu Kandavel, Pandey Paritosh, Arivazhagan Arimappamagan, Santosh Va |
| Co-deletion of 1p/19q as Prognostic and Predictive Biomarker for Patients in West Bohemia with Anaplastic Oligodendroglioma. Anticancer research 2016 Jan 36 (1): 471-6. Polivka Jiri, Polivka Jiri, Repik Tomas, Rohan Vladimir, Hes Ondrej, Topolcan Ondr |
| Genetic landscape of extreme responders with anaplastic oligodendroglioma. Oncotarget 2017 May 8 (22): 35523-35531. Holdhoff Matthias, Cairncross Gregory J, Kollmeyer Thomas M, Zhang Ming, Zhang Peixin, Mehta Minesh P, Werner-Wasik Maria, Souhami Luis, Bahary Jean-Paul, Kwok Young, Hartford Alan C, Chakravarti Arnab, Yegnasubramanian Srinivasan, Vogelstein Bert, Papadopoulos Nickolas, Kinzler Kenneth, Jenkins Robert B, Bettegowda Chet |
| Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis. Journal of neuro-oncology 2017 Jan . Xavier-Magalhães Ana, Oliveira Ana I, de Castro Joana Vieira, Pojo Marta, Gonçalves Céline S, Lourenço Tatiana, Viana-Pereira Marta, Costa Sandra, Linhares Paulo, Vaz Rui, Nabiço Rui, Amorim Júlia, Pinto Afonso A, Reis Rui M, Costa Bruno |
| Machine Learning for Better Prognostic Stratification and Driver Gene Identification Using Somatic Copy Number Variations in Anaplastic Oligodendroglioma. The oncologist 2018 7 23 (12): 1500-1510. Rosenberg Shai, Ducray Francois, Alentorn Agusti, Dehais Caroline, Elarouci Nabila, Kamoun Aurelie, Marie Yannick, Tanguy Marie-Laure, De Reynies Aurélien, Mokhtari Karima, Figarella-Branger Dominique, Delattre Jean-Yves, Idbaih Ahmed, |
| Clinical significance of the 2016 WHO classification in Japanese patients with gliomas. Brain tumor pathology 2018 2 35 (2): 71-80. Iuchi Toshihiko, Sugiyama Takahiro, Ohira Miki, Kageyama Hajime, Yokoi Sana, Sakaida Tsukasa, Hasegawa Yuzo, Setoguchi Taiki, Itami Maki |
| Infrequent RAS mutation is not associated with specific histological phenotype in gliomas. BMC cancer 2021 Sep 21 (1): 1025. Makino Yasuhide, Arakawa Yoshiki, Yoshioka Ema, Shofuda Tomoko, Minamiguchi Sachiko, Kawauchi Takeshi, Tanji Masahiro, Kanematsu Daisuke, Nonaka Masahiro, Okita Yoshiko, Kodama Yoshinori, Mano Masayuki, Hirose Takanori, Mineharu Yohei, Miyamoto Susumu, Kanemura Yonehi |
| Molecular biomarkers and integrated pathological diagnosis in the reclassification of gliomas. Molecular and clinical oncology 2021 6 15 (2): 150. Ruiz María Fernanda, Gennaro María Verónica, Bastone Laura C, Godoy Alicia R, Torruella Mónica, Perez Germán |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: